BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17555594)

  • 1. Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231.
    Turturro F; Friday E; Welbourne T
    BMC Cancer; 2007 Jun; 7():96. PubMed ID: 17555594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
    Turturro F; Von Burton G; Friday E
    Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to dexamethasone is glucose-sensitive in multiple myeloma cell lines.
    Friday E; Ledet J; Turturro F
    J Exp Clin Cancer Res; 2011 Sep; 30(1):81. PubMed ID: 21910912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
    Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
    Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231.
    Vaira S; Friday E; Scott K; Conrad S; Turturro F
    J Cell Physiol; 2012 Feb; 227(2):578-86. PubMed ID: 21448924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells.
    Li X; Rong Y; Zhang M; Wang XL; LeMaire SA; Coselli JS; Zhang Y; Shen YH
    Biochem Biophys Res Commun; 2009 Apr; 381(4):660-5. PubMed ID: 19254690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.
    Shah A; Xia L; Goldberg H; Lee KW; Quaggin SE; Fantus IG
    J Biol Chem; 2013 Mar; 288(10):6835-48. PubMed ID: 23329835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.
    Schulze PC; Yoshioka J; Takahashi T; He Z; King GL; Lee RT
    J Biol Chem; 2004 Jul; 279(29):30369-74. PubMed ID: 15128745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.
    Qi W; Chen X; Gilbert RE; Zhang Y; Waltham M; Schache M; Kelly DJ; Pollock CA
    Am J Pathol; 2007 Sep; 171(3):744-54. PubMed ID: 17675577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
    Mukai N; Nakayama Y; Abdali SA; Yoshioka J
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Txnip C247S mutation protects the heart against acute myocardial infarction.
    Nakayama Y; Mukai N; Wang BF; Yang K; Patwari P; Kitsis RN; Yoshioka J
    J Mol Cell Cardiol; 2021 Jun; 155():36-49. PubMed ID: 33652022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
    Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
    Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.
    He X; Ma Q
    Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing Txnip mRNA and protein levels in pancreatic MIN6 cells reduces reactive oxygen species and restores glucose regulated insulin secretion.
    Rani S; Mehta JP; Barron N; Doolan P; Jeppesen PB; Clynes M; O'Driscoll L
    Cell Physiol Biochem; 2010; 25(6):667-74. PubMed ID: 20511712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High glucose condition upregulated Txnip expression level in rat mesangial cells through ROS/MEK/MAPK pathway.
    Fang S; Jin Y; Zheng H; Yan J; Cui Y; Bi H; Jia H; Zhang H; Wang Y; Na L; Gao X; Zhou H
    Mol Cell Biochem; 2011 Jan; 347(1-2):175-82. PubMed ID: 20953987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway.
    Xu W; Wang L; Li J; Cai Y; Xue Y
    Biomed Pharmacother; 2018 Nov; 107():785-792. PubMed ID: 30142540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.
    Ren Y; Shi Y; Wang Y; Li Y; Wu S; Li H; Zhang Y; Duan H
    FEBS Lett; 2010 Aug; 584(15):3480-5. PubMed ID: 20624390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
    Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TXNIP-mediated crosstalk between oxidative stress and glucose metabolism.
    Kim S; Ge J; Kim D; Lee JJ; Choi YJ; Chen W; Bowman JW; Foo SS; Chang LC; Liang Q; Hara D; Choi I; Kim MH; Eoh H; Jung JU
    PLoS One; 2024; 19(2):e0292655. PubMed ID: 38329960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.
    Dunn LL; Simpson PJ; Prosser HC; Lecce L; Yuen GS; Buckle A; Sieveking DP; Vanags LZ; Lim PR; Chow RW; Lam YT; Clayton Z; Bao S; Davies MJ; Stadler N; Celermajer DS; Stocker R; Bursill CA; Cooke JP; Ng MK
    Diabetes; 2014 Feb; 63(2):675-87. PubMed ID: 24198286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.